Drugs / CS-0777
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00616733 | Mar 2008 → Sep 2010 | multiple sclerosis | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS-0777 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00616733 ↗ |
| Route | Oral | “Oral CS-0777, Administered for 12 Weeks” NCT00616733 ↗ |